EFG
BSX icon

Embree Financial Group’s Boston Scientific BSX Stock Holding History

Embree Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,644
Closed -$291K – 292
2026
Q1 		$291K Buy
+4,644
New +$372K 0.03% 207

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Embree Financial Group's BSX Position: Q2 2026 in Review

Embree Financial Group sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,644 shares — an estimated $291K sold.

Embree Financial Group first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $291K in Q1 2026. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Embree Financial Group reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Embree Financial Group sold 4,644 Boston Scientific shares in Q2 2026, an estimated $291K.
  • Embree Financial Group first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
  • Embree Financial Group's Boston Scientific position peaked at $291K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Embree Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.